Meticulous Research®—a leading global market research company, published a research report titled, ‘3D Cell Culture Market by Product (Low Attachment Surfaces, Hanging Drop Method, Hydrogel, Porous Scaffold, Fibrous Scaffold), Application (Cancer Research, Regenerative Medicine, Tissue Engineering, Drug Discovery), End User - Global Forecast to 2030.’
According to this latest publication from Meticulous Research®, the 3D cell culture market is projected to reach $4.02 billion by 2030, at a CAGR of 15.1% during the forecast period. The growth of this market is driven by increasing cancer research, the growing use of 3D cell culture in drug discovery and toxicology testing, high demand for organ transplants, rising investments and funding for life science research, and the utilization of 3D cell culture models in animal testing. Additionally, emerging economies and a growing focus on regenerative medicine are expected to offer significant market growth opportunities.
The key players operating in the 3D cell culture market are Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), Lonza Group AG (Switzerland), Corning Incorporated (U.S.), UPM-Kymmene Corporation (Finland), REPROCELL Inc. (Japan), SYNTHECON, INCORPORATED (South Africa), InSphero AG (Switzerland), Advanced BioMatrix (U.S.), MIMETAS B.V. (Netherlands), and Greiner Bio-One International GmbH (Austria).
3D Cell Culture Market: Future Outlook
The 3D Cell Culture market is segmented based on Product [Scaffold-free Platforms (Low Attachment Surfaces, Hanging Drop Method), Scaffold-based Platforms (Hydrogels, Porous Scaffolds, Fibrous Scaffolds, Other Scaffold-based Platforms), Accessories and Consumables, and Other Products], Application [Cancer Research, Regenerative Medicines, Drug Discovery and Testing, Tissue Engineering, Other Applications], End User [Pharmaceutical and Biotechnology Companies, Academic and Research Institutes], and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.
Based on product, the 3D cell culture market is segmented into scaffold-free platforms, scaffold-based platforms, accessories and consumables, and other products. In 2023, the scaffold-based platforms segment is expected to account for the largest share of the 3D cell culture market. The scaffold-based platforms segment is further divided into hydrogels, porous scaffolds, fibrous scaffolds, and other scaffold-based platforms. Hydrogels are among the most commonly used scaffolds for 3D cell cultures. Using hydrogels as scaffolds in 3D cell culture research allows for integrating mechanical indicators and advanced biochemical as a mirror of the natural extracellular matrix. Furthermore, the increasing demand for hydrogel improvements to provide stable platforms for studying human and biological physiology, as well as the introduction of novel products, contribute to the large market share of this segment.
Based on application, the 3D cell culture market is segmented into cancer research, regenerative medicines, drug discovery and testing, tissue engineering, and other applications. In 2023, the cancer research segment is expected to account for the largest share of the 3D cell culture market. The numerous advantages offered by 3D cell culture in cancer research, including the ability to analyze gene and protein expression, study cell behavior in a 3D space, and replicate tumor structures, contribute to the large market share of this segment. Furthermore, 3D cell culture enables the study of tumor biology, drug sensitivity, and the replication of the tumor microenvironment, capturing phenotypic heterogeneity and thus supporting advancements in cancer research.
Based on end user, the 3D cell culture market is segmented into pharmaceutical and biotechnology companies and academic and research institutes. In 2023, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the 3D cell culture market. The large market share of this segment can be attributed to various technological advancements in 3D cell culture that help pharmaceutical and biotechnology industries improve precision medicine, pre-clinical validation, and drug discovery. Additionally, increasing research collaborations further contribute to the growth of this segment. For instance, in May 2023, Mirati Therapeutics, Inc. (U.S.) collaborated with Sarah Cannon Research Institute (SCRI) (U.S.) to increase diversity in cancer clinical studies.
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the 3D cell culture market, followed by Europe and Asia-Pacific. Furthermore, in 2023, the U.S. is expected to be the largest market shareholder in North America. North America’s major market share is attributed to the highly developed healthcare infrastructure and the presence of major market players such as Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), and Lonza Group AG (Switzerland).
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=1246
Key questions answered in the report:
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029Read More